CClinicalTrials.gg
CompletedNCT00088764Updated Aug 15, 2013

Pain and Stress Management for People With Rheumatoid Arthritis

A Phase 2 interventional study of Coping skills training and Written emotional disclosure in Rheumatoid Arthritis, sponsored by Wayne State University. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-08-15.

Sponsored by Wayne State University · Phase 2 and Interventional

Phase
Phase 2
Study type
Interventional
Enrollment
280
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Self-management of rheumatoid arthritis (RA) symptoms using written emotional disclosure (ED), coping skills training (CST), or a combination of both may benefit people with RA. The purpose of this study is to determine the benefits of ED, CST, or CST and ED together in adults with RA. This study will be conducted at Wayne State University in Detroit, Michigan and Duke University Medical Center in Durham, North Carolina.

Read the detailed description

Two self-management strategies hold promise for improving the health of people with RA: ED (writing about stress, RA, and coping options) and CST (learning six pain and stress coping skills). A strategy integrating ED with CST may be more effective than either intervention alone. This study will compare the effectiveness of ED, CST, ED in combination with CST, and control groups in alleviating the symptoms of RA.

This study will last until May 2009. Participants with RA will be randomly assigned to 1 of 4 treatment groups. Each participant will receive 3 writing sessions and 8 training sessions. Group 1 will receive ED writing followed by CST; Group 2 will receive ED writing followed by arthritis education; Group 3 will receive health behavior writing followed by CST; and Group 4 will receive health behavior writing followed by arthritis education.

Participants will be evaluated at baseline and at Months 1, 4, and 12 for pain, physical disability, psychological impairment, and disease activity. In addition, participants will record daily diaries for 30 days regarding their pain, symptoms, coping, stress, and mood prior to each of the evaluations. Changes in health status over time will be compared among groups.

02

Conditions studied

  • Rheumatoid Arthritis

Keywords

  • Stress
  • Coping
  • Expressive Writing
  • Self-Efficacy
  • Disclosure
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 280 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Wayne State University is the lead sponsor of 226 studies on the registry; 35 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Meet American College of Rheumatology (ACR) 1987 criteria for RA

Exclusion criteria

Exclusion Criteria:

  • Other disorders that would significantly affect function (e.g., lupus, chronic obstructive pulmonary disease [COPD], congestive heart failure [CHF], cancer)
  • Judged by the physician to have cognitive impairment (dementia, retardation, psychosis) or illiteracy
  • Has experienced recent (last 6 months) significant stressor resulting in substantial emotional instability
  • Currently in psychotherapy or a formal behavioral pain management program
  • Unable to walk. Participants who use walking aids are not excluded.
  • Physically unable to write
05

Study design

Phase
Phase 2
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
280 participants (actual)

Study arms

  • Experimental
    1

    Education: Either coping skills training or arthritis education interventions

    Behavioral: Coping skills training · Behavioral: Arthritis education

  • Experimental
    2

    Writing: Either emotional disclosure writing or health behavior writing

    Behavioral: Written emotional disclosure · Behavioral: Health behavior writing

Interventions

  • BehavioralCoping skills training

    8 sessions of pain and stress coping skills training

  • BehavioralWritten emotional disclosure

    4 sessions of writing about stress

  • BehavioralArthritis education

    8 sessions of learning about rheumatoid arthritis

  • BehavioralHealth behavior writing

    4 sessions of writing about various health behaviors

06

What researchers measure

Primary outcomes

  1. Joint count

    Time frame: one year

Secondary outcomes

  1. Psychological impairment

    Time frame: one year

  2. Pain

    Time frame: one year

  3. Physical disability

    Time frame: one year

  4. C-reactive protein

    Time frame: one year

  5. Fatigue

    Time frame: one year

07

Study locations

2 sites
  • Wayne State University
    Detroit, Michigan 48202, United States
  • Duke University Medical Center
    Durham, North Carolina 27708, United States
08

References and documents

Publications

  • Kelley JE, Lumley MA, Leisen JC. Health effects of emotional disclosure in rheumatoid arthritis patients. Health Psychol. 1997 Jul;16(4):331-40. doi: 10.1037//0278-6133.16.4.331. PubMed 9237085 ↗
  • Somers TJ, Shelby RA, Keefe FJ, Godiwala N, Lumley MA, Mosley-Williams A, Rice JR, Caldwell D. Disease severity and domain-specific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010 Jun;62(6):848-56. doi: 10.1002/acr.20127. PubMed 20535796 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00088764
Lead sponsor
Wayne State University
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
Mark A. Lumley (Professor, Wayne State University) — Principal investigator
First posted
Aug 5, 2004
Start date
Feb 2005
Primary completion
Apr 2009
Completion
Jun 2009
Last update
Aug 15, 2013

Study contacts

Mark A. Lumley, PhD
principal investigator · Wayne State University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion